149 related articles for article (PubMed ID: 11511216)
1. Insulin-enhancing vanadium(III) complexes.
Melchior M; Rettig SJ; Liboiron BD; Thompson KH; Yuen VG; McNeill JH; Orvig C
Inorg Chem; 2001 Aug; 40(18):4686-90. PubMed ID: 11511216
[TBL] [Abstract][Full Text] [Related]
2. Coordination chemistry and insulin-enhancing behavior of vanadium complexes with maltol C6H6O3 structural isomers.
Saatchi K; Thompson KH; Patrick BO; Pink M; Yuen VG; McNeill JH; Orvig C
Inorg Chem; 2005 Apr; 44(8):2689-97. PubMed ID: 15819554
[TBL] [Abstract][Full Text] [Related]
3. Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes.
Thompson KH; Chiles J; Yuen VG; Tse J; McNeill JH; Orvig C
J Inorg Biochem; 2004 May; 98(5):683-90. PubMed ID: 15134913
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and morphological study on liver Golgi complex in streptozotocin-diabetic and control rats treated with bis(kojato)oxovanadium(IV) [VO(ka)2]x2H2O. Part II. Prolonged treatmentwith vanadium compound.
Dabroś W; Gryboś R; Miarka A; Kordowiak AM
Pol J Pathol; 2000; 51(1):17-24. PubMed ID: 10833899
[TBL] [Abstract][Full Text] [Related]
6. Vanadium complexes with mixed O,S anionic ligands derived from maltol: synthesis, characterization, and biological studies.
Monga V; Thompson KH; Yuen VG; Sharma V; Patrick BO; McNeill JH; Orvig C
Inorg Chem; 2005 Apr; 44(8):2678-88. PubMed ID: 15819553
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic treatment with Bis(maltolato)oxovanadium (IV) in rat model of non-insulin-dependent-diabetes.
Shinde UA; Mehta AA; Goyal RK
Indian J Exp Biol; 2001 Sep; 39(9):864-70. PubMed ID: 11831366
[TBL] [Abstract][Full Text] [Related]
8. Glucose-lowering properties of vanadium compounds: comparison of coordination complexes with maltol or kojic acid as ligands.
Yuen VG; Caravan P; Gelmini L; Glover N; McNeill JH; Setyawati IA; Zhou Y; Orvig C
J Inorg Biochem; 1997 Nov; 68(2):109-16. PubMed ID: 9336969
[TBL] [Abstract][Full Text] [Related]
9. The influence of BMOV [bis(maltolato)oxovanadium(IV)] on biochemical and morphological alterations characteristic for streptozotocin-diabetic rat liver Golgi complexes.
Dabroś W; Dziga D; Kordowiak AM
Pol J Pathol; 2002; 53(4):205-13. PubMed ID: 12597338
[TBL] [Abstract][Full Text] [Related]
10. The influence of a new vanadium compound, bis(2,2'-bipyridine)oxovanadium(IV) sulphate on liver golgi complexes from control and streptozotocin-diabetic rats.
Kordowiak AM; Dabroś W; Kajda B
Horm Metab Res; 2002 Oct; 34(10):556-60. PubMed ID: 12439783
[TBL] [Abstract][Full Text] [Related]
11. Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats.
Buglyó P; Crans DC; Nagy EM; Lindo RL; Yang L; Smee JJ; Jin W; Chi LH; Godzala Iii ME; Willsky GR
Inorg Chem; 2005 Jul; 44(15):5416-27. PubMed ID: 16022540
[TBL] [Abstract][Full Text] [Related]
12. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes.
Adachi Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H
J Med Chem; 2006 Jun; 49(11):3251-6. PubMed ID: 16722643
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and anti-diabetic therapeutic potential of a new benzyl acid-derivatized kojic acid vanadyl complex.
Wei YB; Yang XD
Biometals; 2012 Dec; 25(6):1261-8. PubMed ID: 23015214
[TBL] [Abstract][Full Text] [Related]
14. Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV).
Willsky GR; Goldfine AB; Kostyniak PJ; McNeill JH; Yang LQ; Khan HR; Crans DC
J Inorg Biochem; 2001 May; 85(1):33-42. PubMed ID: 11377693
[TBL] [Abstract][Full Text] [Related]
15. Vanadium treatment of type 2 diabetes: a view to the future.
Thompson KH; Lichter J; LeBel C; Scaife MC; McNeill JH; Orvig C
J Inorg Biochem; 2009 Apr; 103(4):554-8. PubMed ID: 19162329
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
Yuen VG; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
[TBL] [Abstract][Full Text] [Related]
17. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
[TBL] [Abstract][Full Text] [Related]
18. Chloro-substituted dipicolinate vanadium complexes: synthesis, solution, solid-state, and insulin-enhancing properties.
Smee JJ; Epps JA; Ooms K; Bolte SE; Polenova T; Baruah B; Yang L; Ding W; Li M; Willsky GR; la Cour A; Anderson OP; Crans DC
J Inorg Biochem; 2009 Apr; 103(4):575-84. PubMed ID: 19201030
[TBL] [Abstract][Full Text] [Related]
19. Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV).
Yuen VG; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1993; 71(3-4):263-9. PubMed ID: 8402390
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and morphological study on liver Golgi complex in streptozotocin-diabetic and control rats treated with bis(kojato)oxovanadium(IV) [VO(ka)2]x2H2O. Part I. One week treatment with vanadium compound.
Kordowiak AM; Nikiforuk A; Dabroś W
Pol J Pathol; 2000; 51(1):9-16. PubMed ID: 10833898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
